share_log
Moomoo 24/7 ·  Feb 21 11:19
Kazia Therapeutics Shares Are Trading Lower, After Initally Spiking Higher, Amid Increased Volatility in the Stock After the Company Announced the Early Conclusion of the Phase 1 Paxalisib Trial in Solid Tumors After Reaching the Primary Endpoint
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment